PROSTATE NEOPLASMS
Clinical trials for PROSTATE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new PROSTATE NEOPLASMS trials appear
Sign up with your email to follow new studies for PROSTATE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a few weeks of radiation be enough for recurrent prostate cancer?
Disease control CompletedThis early-phase trial tested a shorter course of radiation for men whose prostate cancer came back after their prostate was removed. Instead of the usual 6-7 weeks of daily radiation, researchers gave higher doses over just 2-4 weeks, focusing the strongest radiation on the tumo…
Matched conditions: PROSTATE NEOPLASMS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Vaccine-Chemo combo shows promise against spread prostate cancer
Disease control CompletedThis study tested whether adding a prostate cancer vaccine (PROSTVAC) and chemotherapy (docetaxel) to standard hormone therapy works better than hormone therapy alone for men whose prostate cancer has spread. 74 men with metastatic castration-sensitive prostate cancer took part. …
Matched conditions: PROSTATE NEOPLASMS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Real-World data reveals treatment patterns for advanced prostate cancer
Knowledge-focused CompletedThis study reviewed medical records from over 1,300 men with metastatic prostate cancer that still responds to hormone therapy. Researchers wanted to see how long patients actually take the pills apalutamide or enzalutamide when prescribed by their own doctors in routine care. Th…
Matched conditions: PROSTATE NEOPLASMS
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC